These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9394771)

  • 41. Helicobacter pylori in children: an Indian perspective.
    Poddar U; Yachha SK
    Indian Pediatr; 2007 Oct; 44(10):761-70. PubMed ID: 17998576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.
    Maleki Kakelar H; Barzegari A; Dehghani J; Hanifian S; Saeedi N; Barar J; Omidi Y
    Gastric Cancer; 2019 Jan; 22(1):23-36. PubMed ID: 30145749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helicobacter pylori infection: detection, investigation, and management.
    Czinn SJ
    J Pediatr; 2005 Mar; 146(3 Suppl):S21-6. PubMed ID: 15758899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why guidelines are required for the treatment of Helicobacter pylori infection in children.
    Sherman PM; Hunt RH
    Clin Invest Med; 1996 Oct; 19(5):362-7. PubMed ID: 8889275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low point prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection.
    Anand BS; Raed AK; Malaty HM; Genta RM; Klein PD; Evans DJ; Graham DY
    Am J Gastroenterol; 1996 Jun; 91(6):1112-5. PubMed ID: 8651154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Eradication of Helicobacter pylori in Japan].
    Kamimoto H; Fukuda Y; Tamura K; Shimoyama T
    Nihon Rinsho; 1999 Jun; 57(6):1435-41. PubMed ID: 10391015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori and Gastrointestinal Malignancies.
    Venerito M; Vasapolli R; Rokkas T; Malfertheiner P
    Helicobacter; 2015 Sep; 20 Suppl 1():36-9. PubMed ID: 26372823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt.
    Said Essa A; Alaa Eldeen Nouh M; Mohammed Ghaniam N; Graham DY; Said Sabry H
    Scand J Infect Dis; 2008; 40(9):730-3. PubMed ID: 19086246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
    Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer.
    Konturek JW
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():23-41. PubMed ID: 15075463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori and peptic ulcer disease.
    Blum AL
    Scand J Gastroenterol Suppl; 1996; 214():24-7; discussion 42-3. PubMed ID: 8722401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter Pylori and Gastric Cancer: Clinical Aspects.
    Song ZQ; Zhou LY
    Chin Med J (Engl); 2015 Nov; 128(22):3101-5. PubMed ID: 26608993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Helicobacter pylori and gastrointestinal disease.
    Pezzi JS; Shiau YF
    Am Fam Physician; 1995 Nov; 52(6):1717-24, 1729. PubMed ID: 7484682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
    Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
    J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
    Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
    Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Helicobacter pylori: criminal or innocent bystander?
    Arakawa T; Higuchi K; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Uchida T; Kuroki T
    J Gastroenterol; 2000; 35 Suppl 12():42-6. PubMed ID: 10779217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies used by
    Abadi ATB
    World J Gastroenterol; 2017 Apr; 23(16):2870-2882. PubMed ID: 28522905
    [No Abstract]   [Full Text] [Related]  

  • 60. Helicobacter pylori: a perspective in low- and middle-income countries.
    Poddar U
    Paediatr Int Child Health; 2019 Feb; 39(1):13-17. PubMed ID: 29987976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.